See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 20, 2003

Allergy Sickle Cell Disease Ovarian Cancer

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Allergy

A research study of an investigational medication for nasal allergy. Volunteers 12 and older who have been suffering from nasal allergy for the last two years may be eligible. Research site located in Los Angeles, California.

More Information

Please see http://www.centerwatch.com/patient/studies/cat166.html.

-----

Sickle Cell Disease

A study to assess the safety and tolerability of an investigational drug in sickle cell patients with iron overload due to chronic transfusion. Volunteers age 18 or older who have been diagnosed with sickle cell disease and have received blood transfusions that resulted in transfusional iron overload may be eligible. Research site located in Columbus, Ohio.

More Information

Please see http://www.centerwatch.com/patient/studies/cat627.html.

-----

Ovarian Cancer

A research study of an investigational medication for ovarian cancer. Female volunteers age 18 or older who have stage III/IV ovarian cancer may be eligible. Research site located in Tampa, Florida.

More Information

Please see http://www.centerwatch.com/patient/studies/cat186.html.

-----

Copyright 2003 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.